These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3706517)

  • 1. LLC-PK1 cells: cloning of phenotypically stable subpopulations.
    Wohlwend A; Vassalli JD; Belin D; Orci L
    Am J Physiol; 1986 May; 250(5 Pt 1):C682-7. PubMed ID: 3706517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin and vasopressin affect epithelial properties in a renal cell line.
    Wohlwend A; Vassalli JD; Bertrand D; Orci L
    J Cell Physiol; 1986 Jul; 128(1):71-5. PubMed ID: 3013907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP.
    Andrus L; Altus MS; Pearson D; Grattan M; Nagamine Y
    J Biol Chem; 1988 May; 263(13):6183-7. PubMed ID: 3360780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLC-PK1.
    Dayer JM; Vassalli JD; Bobbitt JL; Hull RN; Reich E; Krane SM
    J Cell Biol; 1981 Oct; 91(1):195-200. PubMed ID: 6271791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
    Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y
    Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LLC-PK1 cysts: a model for the study of epithelial polarity.
    Wohlwend A; Montesano R; Vassalli JD; Orci L
    J Cell Physiol; 1985 Dec; 125(3):533-9. PubMed ID: 4066772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function.
    Jans DA; Resink TJ; Wilson LE; Reich E; Hemmings BA
    Eur J Biochem; 1986 Oct; 160(2):407-12. PubMed ID: 3021458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability.
    Altus MS; Pearson D; Horiuchi A; Nagamine Y
    Biochem J; 1987 Mar; 242(2):387-92. PubMed ID: 3593259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin and calcitonin gene-related peptide interact with the same receptor in cultured LLC-PK1 kidney cells.
    Wohlwend A; Malmström K; Henke H; Murer H; Vassalli JD; Fischer JA
    Biochem Biophys Res Commun; 1985 Sep; 131(2):537-42. PubMed ID: 2996513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
    Luzius H; Jans DA; Jans P; Fahrenholz F
    Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells.
    Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D
    Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel expression system for Gs-coupled receptors.
    Catanzariti L; Allen JM; Hemmings BA
    Biotechniques; 1993 Sep; 15(3):474-9. PubMed ID: 8217161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, enzyme activity, sugar transport, and hormone supplement responses in cells cloned from a pig kidney cell line LLC-PK1.
    Miller JH; Heath LN
    J Cell Physiol; 1989 Jun; 139(3):538-49. PubMed ID: 2567738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal regulation of protein synthesis in cultured kidney cells.
    Sudol M
    Mol Cell Endocrinol; 1985 May; 40(2-3):245-55. PubMed ID: 2408939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A system to select for mutant LLC-PK1 cells affected in cAMP mediated hormonal response using a photoactivatable analogue of vasopressin.
    Luzius H; Jans DA; Fahrenholz F
    J Recept Res; 1990; 10(1-2):61-80. PubMed ID: 2175811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells.
    Nagamine Y; Sudol M; Reich E
    Cell; 1983 Apr; 32(4):1181-90. PubMed ID: 6687701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP modulates transepithelial resistance response of LLC-PK1 renal epithelia to tumor necrosis factor.
    Marano CW; Laughlin KV; Russo LM; Short TH; Mullin JM
    Am J Physiol; 1995 Feb; 268(2 Pt 2):F315-22. PubMed ID: 7864172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tight junctional resistance on penetration of LLC-PK1 epithelial cell layers by metastatic B16-F10 melanoma cells.
    Conn KG; Knudsen KA
    Cancer Res; 1989 Dec; 49(24 Pt 1):7098-105. PubMed ID: 2582451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.